Locations:
Search
Melanoma may be more heritable than we think
Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib
Disease-related, clinical and discharge-associated factors
Multicenter study shows survival benefit for patients ≤ 65
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
JAK inhibitors, the hedgehog pathway and answers for anemia
Prevention, early detection best strategy
Researchers add genomic data to their model
Prospective study needed to determine best margins
Helps reduce risk of premature menopause
Finding variants of uncertain significance does not increase the rate of contralateral prophylactic mastectomies
Advertisement
Advertisement